MedTrace Logo

Role of 18F-FDG PET/CT in the Evaluation of Cavernous Sinus Syndrome: a Pilot Study

NCT06721130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2024-12-06

No results posted yet for this study

Summary

Cavernous sinus syndrome (CSS) can be caused by a wide range of inflammatory, malignant, benign, vascular and miscellaneous disorders. Even after modern advances, reaching the final etiological diagnosis remains a challenge in CSS. This study is planned to determine the role and incremental value of 18F-FDG PET/CT in characterising different cavernous sinus pathologies based on their metabolic activity and detecting extracranial involvement.

Conditions

  • Cavernous Sinus Syndrome
  • Cavernous Sinus Meningioma
  • Cavernous Sinus Lesions

Interventions

DIAGNOSTIC_TEST

FDG radiotracer

Pilot study evaluating the role of FDG PET/CT in Cavernous sinus syndrome

Sponsors & Collaborators

  • Post Graduate Institute of Medical Education and Research, Chandigarh

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2023-12-31
Completion
2024-06-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06721130 on ClinicalTrials.gov